Symposium 2A: Colon Cancer in 2026: Redefining Standards through Evidence and Experience

23 Jul 2026 15:30 17:00
Ballroom 2
Dursun Bugra Chairperson Turkey
LU PING YAN Chairperson
Time Session
15:30
15:45
Neoadjuvant Therapy in Locally Advanced Colon Cancer. Lessons, Limitations, and the FOxTROT Legacy
Fuad Ismail Speaker Malaysia
Ballroom 2
15:45
16:00
Is the Knife Over? MSI — The New Game Changer in Colorectal Cancer
Mathangi Chandramouli Speaker India
Ballroom 2
16:00
16:15
The Biology behind the Mesocolon. Is D3 & CME Really Changing Oncologic Outcomes?
Richard Fortunato Speaker United States
Ballroom 2
16:15
16:30
Circulating Tumour DNA (ctDNA): Preventing Overtreatment in Stage II/III Disease and Transforming Surveillance
Choo Su Pin Speaker Singapore
Ballroom 2
16:30
16:45
Beyond the Right Colon: Does Tumour Location Determine the Extend of Resection?
Vitaliy Poylin Speaker United States
Ballroom 2
16:45
17:00
Q&A
Ballroom 2